For nearly forty years, feminists and patient activists have argued that medicine is a deeply individualizing and depoliticizing institution. According to this view, medical practices are incidental to people’s transformation from patients to patient activists. The Biopolitics of Breast Cancer turns this understanding upside down. Maren Klawiter analyzes the evolution of the breast cancer movement to show the broad social impact of how diseases come to be medically managed and publicly administered. Examining surgical procedures, adjuvant therapies, early detection campaigns, and the rise in discourses of risk, Klawiter demonstrates that these practices created a change in the social relations-if not the mortality rate-of breast cancer that initially inhibited, but later enabled, collective action. Her research focuses on the emergence and development of new forms of activism that range from grassroots patient empowerment to environmental activism and corporate-funded breast cancer awareness. The Biopolitics of Breast Cancer opens a window onto a larger set of changes currently transforming medically advanced societies and ultimately challenges our understanding of the origins, politics, and future of the breast cancer movement. Maren Klawiter holds a PhD in sociology from the University of California, Berkeley. She is currently pursuing a law degree at Yale University.

"Taking Charge of Breast Cancer incorporates many components of the experience of breast cancer, from personal illness to political economic factors. Based on her very extensive data from interviews and content analysis, Ericksen's fine writing offers a powerful narrative approach that focuses on stages of awareness and action. In the process she eloquently addresses the physical and emotional consequences of breast surgery, changes in body and sexuality, and activism. This is a major contribution to understanding the politics and experience of breast cancer."—Phil Brown, Brown University

"For several decades, the field of bioethics has played a dominant role in shaping the way society thinks about ethical problems related to developments in science, technology, and medicine. But its traditional emphases on, for example, doctor-patient relationships, informed consent, and individual autonomy have led the field to not be fully responsive to the challenges posed by new human biotechnologies such as assisted reproduction, human genetic enhancement, and DNA forensics. Beyond Bioethics provides a focused overview for students and others grappling with the profound social dilemmas posed by these developments. It brings together the work of cutting-edge thinkers from diverse fields of study and public engagement, all of them committed to a new perspective that is grounded in social justice and public interest values. The contributors to this volume seek to define an emerging field of scholarly, policy, and public concern: a new biopolitics."--Provided by publisher.

In 2000, the National Human Genome Research Institute announced the completion of a “draft” of the human genome, the sequence information of nearly all 3 billion base pairs of DNA. In the wake of this major scientific accomplishment, the focus on the genetic basis of disease has sparked many controversies as questions are raised about radical preventative therapies, the role of race in research, and the environmental origins of illness. In The Material Gene, Kelly Happe explores the cultural and social dimensions of our understandings of genomics, using this emerging field to examine the physical manifestation of social relations. Situating contemporary genomics medicine and public health within a wider history of eugenics, Happe examines how the relationship between heredity and dominant social and economic interests has shifted along with transformations in gender and racial politics, social movement, and political economy. Happe demonstrates that genomics is a type of social knowledge, relying on cultural values to attach meaning to the body. The Material Gene situates contemporary genomics within a history of genetics research yet is attentive to the new ways in which knowledge claims about heredity, race, and gender emerge and are articulated to present-day social and political agendas. Kelly E. Happe is assistant professor of communication studies and women’s studies at the University of Georgia.

Explores the hidden costs of the pink ribbon as an industry and analyzes the social impact on women living with breast cancer -- the stereotypes and the stigmas.

Bearing Witness is a collection of stories from women who went through the diagnosis of ovarian cancer, and treatment for it, only to find that the cancer recurred and any hope of recovery was gone. These women represent a spectrum of ages, ethnic backgrounds, marital circumstances, and professional experiences. From their stories we learn how each woman shapes the meaning of her life. Facing a life crisis can make one bitter and angry, but it can also provide the key to a thankful and generous spirit within. Storytelling is an important art form present in many cultures: it is a way of processing life events, of searching for meaning, and of allowing teller and listener to wrestle with the message. It is a form of teaching and learning. For the women in Bearing Witness, stories are tangible legacies for family and friends and a chance to share their thoughts on living with the “glass half full.” They inspire the reader to reflect on life’s struggles and to find within themselves a sense of optimism, perhaps when they least expect to. Kathryn Carter’s concluding essay places these stories in the context of contemporary discourses of illness and healing.

Roberto Esposito is one of the most prolific and important exponents of contemporary Italian political theory. Bíos-his first book to be translated into English-builds on two decades of highly regarded thought, including his thesis that the modern individual-with all of its civil and political rights as well as its moral powers-is an attempt to attain immunity from the contagion of the extraindividual, namely, the community. In Bíos, Esposito applies such a paradigm of immunization to the analysis of the radical transformation of the political into biopolitics. Bíos discusses the origins and meanings of biopolitical discourse, demonstrates why none of the categories of modern political thought is useful for completely grasping the essence of biopolitics, and reconstructs the negative biopolitical core of Nazism. Esposito suggests that the best contemporary response to the current deadly version of biopolitics is to understand what could make up the elements of a positive biopolitics-a politics of life rather than a politics of mastery and negation of life. In his introduction, Timothy Campbell situates Esposito's arguments within American and European thinking on biopolitics. A comprehensive, illuminating, and highly original treatment of a critically important topic, Bíos introduces an English-reading public to a philosophy that will critically impact such wide-ranging current debates as stem cell research, euthanasia, and the war on terrorism. Roberto Esposito teaches contemporary philosophy at the Italian Institute for the Human Sciences in Naples. His books include Categorie dell impolitico, Nove pensieri sulla politica, Communitas: orgine e destino della comunità, and Immunitas: protezione e negazione della vita. Timothy Campbell is associate professor of Italian studies in the Department of Romance Studies at Cornell University and the author of Wireless Writing in the Age of Marconi (Minnesota, 2006).

A study of the development and rejection of vitamin C as a treatment for cancer, this text also explores the evaluation process of such a contentious treatment. Based on social, economic and financial considerations, it sees these decisions as political rather than objective assessments.

A trenchant analysis of the dark side of regulatory life-making today In their seemingly relentless pursuit of life, do contemporary U.S. “biocultures”—where biomedicine extends beyond the formal institutions of the clinic, hospital, and lab to everyday cultural practices—also engage in a deadly endeavor? Challenging us to question their implications, Deadly Biocultures shows that efforts to “make live” are accompanied by the twin operation of “let die”: they validate and enhance lives seen as economically viable, self-sustaining, productive, and oriented toward the future and optimism while reinforcing inequitable distributions of life based on race, class, gender, and dis/ability. Affirming life can obscure death, create deadly conditions, and even kill. Deadly Biocultures examines the affirmation to hope, target, thrive, secure, and green in the respective biocultures of cancer, race-based health, fatness, aging, and the afterlife. Its chapters focus on specific practices, technologies, or techniques that ostensibly affirm life and suggest life’s inextricable links to capital but that also engender a politics of death and erasure. The authors ultimately ask: what alternative social forms and individual practices might be mapped onto or intersect with biomedicine for more equitable biofutures?

This unique, research-based investigation of the U.S. breast cancer movement compares the "pink" and "green" efforts within the movement and documents their use of similar citizen-science alliances, despite the contention over the use of consumer-based activism and pink products. Breast cancer activism is one of the most flourishing research and health advocacy movements in U.S. history. Yet the incidence of breast cancer is continuing to increase. This critical and revealing text investigates breast cancer activism in its two forms—the "pink movement" that focuses on developing awareness of, coping with, and managing breast cancer; and the "green movement" that strives to determine the possible environmental causes of breast cancer—such as pesticides, chemicals, and water and air pollution—and thereby hopes to prevent breast cancer. What caused this new green movement to develop? Will it replace or merge with the pink movement? Does either approach offer more promise for a solution? And how do the two movements differ in their positions or methodology towards a similar goal? With information culled from interviews with more than 50 industry stakeholders, The Green Solution to Breast Cancer: A Promise for Prevention argues that key attributes such as strategy, mission, and branding have led to a greater convergence between the pink and green wings of the movement and presents information that enables readers to consider if either approach might be the shorter route to beating breast cancer.